BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25822471)

  • 1. Hepatic Parenchymal Heterogeneity on Contrast-enhanced CT Scans Following Oxaliplatin-based Chemotherapy: Natural History and Association with Clinical Evidence of Sinusoidal Obstruction Syndrome.
    Han NY; Park BJ; Kim MJ; Sung DJ; Cho SB
    Radiology; 2015 Sep; 276(3):766-74. PubMed ID: 25822471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Parenchymal Heterogeneity as a Marker for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: Correlation With Treatment Response of Colorectal Cancer Liver Metastases.
    Han NY; Park BJ; Yang KS; Kim MJ; Sung DJ; Sim KC; Cho SB
    AJR Am J Roentgenol; 2017 Nov; 209(5):1039-1045. PubMed ID: 28813196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.
    Cayet S; Pasco J; Dujardin F; Besson M; Orain I; De Muret A; Miquelestorena-Standley E; Thiery J; Genet T; Le Bayon AG
    Eur J Radiol; 2017 Sep; 94():180-190. PubMed ID: 28712693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.
    Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rather M; Rosso E; Addeo P; Jaeck D; Bachellier P
    Ann Surg Oncol; 2012 Jul; 19(7):2230-7. PubMed ID: 22402811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy.
    Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T; Hanaoka J; Kanamoto M; Iwahashi S; Saito Y; Yamada S; Asanoma M; Takasu C; Bando Y
    Anticancer Res; 2014 Apr; 34(4):1953-8. PubMed ID: 24692731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-EOB-DTPA-enhanced MR findings in chemotherapy-induced sinusoidal obstruction syndrome in colorectal liver metastases.
    Ding Y; Rao SX; Wang WT; Chen CZ; Li RC; Zeng M
    J Int Med Res; 2020 Jun; 48(6):300060520926031. PubMed ID: 32500783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome.
    Imai K; Emi Y; Iyama KI; Beppu T; Ogata Y; Kakeji Y; Samura H; Oki E; Akagi Y; Maehara Y; Baba H;
    Eur J Surg Oncol; 2014 May; 40(5):559-566. PubMed ID: 24388740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid--enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation.
    Han NY; Park BJ; Sung DJ; Kim MJ; Cho SB; Lee CH; Jang YJ; Kim SY; Kim DS; Um SH; Won NH; Yang KS
    Radiology; 2014 May; 271(2):416-25. PubMed ID: 24475862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.
    Overman MJ; Maru DM; Charnsangavej C; Loyer EM; Wang H; Pathak P; Eng C; Hoff PM; Vauthey JN; Wolff RA; Kopetz S
    J Clin Oncol; 2010 May; 28(15):2549-55. PubMed ID: 20406923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hepatic FDG uptake on PET/CT in hepatic sinusoidal obstructive syndrome.
    Kim H; Baek SE; Moon J; Roh YH; Lee N; Cho A
    Oncotarget; 2016 Oct; 7(42):69024-69031. PubMed ID: 27602584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.
    Morris-Stiff G; Tan YM; Vauthey JN
    Eur J Surg Oncol; 2008 Jun; 34(6):609-14. PubMed ID: 17764887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative assessment of chemotherapeutic associated liver injury based on indocyanine green retention test.
    Russolillo N; Langella S; Perotti S; Lo Tesoriere R; Forchino F; Ferrero A
    Int J Surg; 2016 Jul; 31():80-5. PubMed ID: 27260311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
    Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
    PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance assessment of sinusoidal obstruction syndrome after neoadjuvant chemotherapy for colorectal liver metastases is not reproducible.
    Staal FC; Beets-Tan RG; Heeres BC; Houwers J; de Boer M; van Dorth D; Lambregts DM; Maas M
    Acta Radiol; 2021 Sep; 62(9):1133-1141. PubMed ID: 32972213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome.
    Wang C; Wu X; Xie W; Ren X; Zhang W; Xu J
    Sci Rep; 2019 Feb; 9(1):2179. PubMed ID: 30778132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.
    van den Broek MA; Vreuls CP; Winstanley A; Jansen RL; van Bijnen AA; Dello SA; Bemelmans MH; Dejong CH; Driessen A; Olde Damink SW
    Ann Surg Oncol; 2013 May; 20(5):1462-9. PubMed ID: 23463086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.
    Seo AN; Kim H
    Clin Mol Hepatol; 2014 Mar; 20(1):81-4. PubMed ID: 24757663
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
    Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A
    Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.